regadenoson
Generic: regadenoson
Labeler: apotex corp.Drug Facts
Product Profile
Brand Name
regadenoson
Generic Name
regadenoson
Labeler
apotex corp.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
regadenoson .08 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
60505-6288
Product ID
60505-6288_a21106e5-4b14-7a34-523c-eb93b424d43d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207604
Listing Expiration
2026-12-31
Marketing Start
2025-04-03
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
605056288
Hyphenated Format
60505-6288
Supplemental Identifiers
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
regadenoson (source: ndc)
Generic Name
regadenoson (source: ndc)
Application Number
ANDA207604 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .08 mg/mL
Packaging
- 1 SYRINGE, PLASTIC in 1 CARTON (60505-6288-0) / 5 mL in 1 SYRINGE, PLASTIC
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "a21106e5-4b14-7a34-523c-eb93b424d43d", "openfda": {"nui": ["N0000178375", "N0000175788"], "unii": ["2XLN4Y044H"], "spl_set_id": ["88909dc6-502a-61b1-b8e1-22a42da65847"], "pharm_class_epc": ["Adenosine Receptor Agonist [EPC]"], "pharm_class_moa": ["Adenosine Receptor Agonists [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (60505-6288-0) / 5 mL in 1 SYRINGE, PLASTIC", "package_ndc": "60505-6288-0", "marketing_start_date": "20250403"}], "brand_name": "Regadenoson", "product_id": "60505-6288_a21106e5-4b14-7a34-523c-eb93b424d43d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adenosine Receptor Agonists [MoA]", "Pharmacologic Cardiac Stress Test Agent [EPC]"], "product_ndc": "60505-6288", "generic_name": "regadenoson", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Regadenoson", "active_ingredients": [{"name": "REGADENOSON", "strength": ".08 mg/mL"}], "application_number": "ANDA207604", "marketing_category": "ANDA", "marketing_start_date": "20250403", "listing_expiration_date": "20261231"}